IP Library › Granted Patent US 11,209,431
Granted Patent B2
US 11,209,431 · App. 15/766,525 · Granted Dec 28, 2021

Patent

Inventors: Michelle Delanoy (Hercules, CA); John Flanagan (Hercules, CA); Audrey Arjomandi (Hercules, CA); Ravi Kaul (Hercules, CA); Steven R. Binder (Hercules, CA)
Assignee: BIO-RAD LABORATORIES, INC.
G01N33/56911A61K39/0225C07K14/20G01N2333/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,209,431
App. No.
15/766,525
Granted
Dec 28, 2021
Kind
B2
Abstract

The present invention relates to an immunoassay for the detection of Borrelia specific IgG, IgM and IgG/IgM antibodies in biological samples suspected of Lyme infection. The immunoassay can be performed via a standard immunoassay format or on an automated platform. In various embodiments, the immunoassay uses one or more Borrelia specific chimeric peptides VlsE-FlaB (designated pFlaB-mV), VlsE-ErpP (designated pErp59-mV), VlsE-P35 (designated pP35-mV) alone or in combination with one or more outer surface protein C (Osp C) types B or I, p58 and DbpA. Other aspects of the invention provide antigen/substrate combinations and compositions comprising combinations of the disclosed peptides and/or proteins for use in the immunoassays described herein.

Claims (18)

1. A substrate comprising SEQ ID NO: 2 and SEQ ID NO: 5 each immobilized on said substrate.

2. The substrate according to claim 1 , wherein said substrate is glass, plastic, polystyrene or nitrocellulose.

3. The substrate according to claim 1 , wherein said substrate is: a) a particle; b) a bead; c) a chip; d) a microchip; e) a lateral flow substrate; or f) a microtiter plate.

4. The substrate according to claim 3 , wherein said substrate is a particle or bead or a population of particles or beads.

5. The substrate according to claim 4 , wherein said substrate is a population of particles or beads comprising two or more separate subpopulations of particles or beads, each subpopulation of particles or beads being distinguishable by a specific detectable physical parameter, SEQ ID NO: 2 being immobilized on one subpopulation of particles or beads, and SEQ ID NO: 5 being immobilized on a second subpopulation of particles or beads.

6. The substrate according to claim 5 , wherein each of the two or more separate subpopulations of particles or beads has a separate specific detectable physical parameter.

7. The substrate according to claim 6 , wherein the specific detectable physical parameter is a fluorescent dye, fluorophore, luminescent agent, electron-dense reagent, radioisotope or particle size.

8. The substrate according to claim 7 , wherein the specific detectable physical parameter is a fluorophore.

9. A method of detecting antibodies specific to SEQ ID NO: 2 and/or SEQ ID NO: 5 in a mammal comprising obtaining a biological sample from the mammal, contacting said biological sample with the substrate according to claim 1 and detecting the presence or the absence of the antibodies that are bound specifically to SEQ ID NO: 2 and/or SEQ ID NO: 5.

10. The method according to claim 9 , wherein said method comprises contacting the biological sample with the substrate, wherein the substrate comprises a population of particles or beads comprising two or more separate subpopulations of particles or beads, each subpopulation of particles or beads being distinguishable by a specific detectable physical parameter, SEQ ID NO: 2 being immobilized on one subpopulation of particles or beads, and SEQ ID NO: 5 being immobilized on a second subpopulation of particles or beads.

11. The method according to claim 10 , wherein each of said two or more separate subpopulations of particles or beads has a separate specific detectable physical parameter.

12. The substrate according to claim 5 , wherein said population of beads further comprises SEQ ID NO: 8 immobilized on a third subpopulation of beads or particles having a third specific detectable physical parameter.

13. The substrate according to claim 1 , said substrate further comprising SEQ ID NO: 8 immobilized on said substrate.

14. The substrate according to claim 12 , wherein the specific detectable physical parameter is a fluorescent dye, fluorophore, luminescent agent, electron-dense reagent, radioisotope or particle size.

15. The substrate according to claim 14 , wherein the specific detectable physical parameter is a fluorophore.

16. The method according to claim 10 , wherein said population of particles or beads further comprises SEQ ID NO: 8 immobilized on a third subpopulation of particles or beads having a third specific detectable physical parameter.

17. The method according to claim 10 , wherein the separate specific detectable physical parameter is a fluorescent dye, fluorophore, luminescent agent, electron-dense reagent, radioisotope or particle size.

18. The substrate according to claim 1 , wherein the immobilization comprises covalent or non-covalent binding of SEQ ID NO: 2 and SEQ ID NO: 5 to the substrate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 19, 2018
From: DELANOY, MICHELLE; FLANAGAN, JOHN; ARJOMANDI, AUDREY; KAUL, RAVI; BINDER, STEVEN R.
To: BIO-RAD LABORATORIES, INC
Reel/Frame 045587/0731 →
Continuity (2)
Provisional Application 62237846 · Oct 6, 2015
Related Publication 20190025303A1 · Jan 24, 2019
Cited By (2)
US 12,188,931 US 12,638,446